Van Ginckel R, Distelmans W, De Brabander M, Callens M, Janssens B, Jagers E, Wouters L, De Coster R, Janssen P A
Janssen Research Foundation, Beerse.
Eur J Cancer. 1992;28A(6-7):1137-9. doi: 10.1016/0959-8049(92)90473-f.
Fragments of human colorectal adenocarcinomas were inserted under the renal capsule of nude mice. The growth of these tumour grafts was significantly inhibited by the combination of 5-fluorouracil (5-FU) and levamisole. An alternating regimen of levamisole 2.5 mg/kg and 5-FU 20 mg/kg decreased the size of tumour implants by 33-59% and/or increased the number of macroscopically disappeared fragments in the combined group compared with ineffective monotherapy with saline, levamisole or 5-FU. This model could be valuable for investigating the mechanism of action of levamisole and to evaluate the effects of this adjuvant therapy in other oncological settings.